Use of Conductivity for the Correction of Urinary N-telopeptide

被引:0
|
作者
Johnson, S. R. [1 ]
Carlilse, S. [1 ]
Krishnankutty, A. [1 ]
Higgs, K. [1 ]
Zak, K. [1 ]
机构
[1] R&D SPD, Bedford, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S191 / S191
页数:1
相关论文
共 50 条
  • [41] Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases
    Masato Shizuku
    Masahiro Shibata
    Mai Okumura
    Dai Takeuchi
    Toyone Kikumori
    Yutaka Mizuno
    Breast Cancer, 2020, 27 : 1065 - 1071
  • [42] Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease
    Dresner-Pollak, R
    Karmeli, F
    Eliakim, R
    Ackerman, Z
    Rachmilewitz, D
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (03): : 699 - 704
  • [43] Normalization of urinary N-telopeptide levels by zoledronic acid correlates with improved survival in patients with bone metastases from breast cancer.
    Lipton, A
    Hei, YJ
    Coleman, RE
    Major, P
    Smith, M
    Cook, RJ
    Milton, S
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S129 - S129
  • [44] Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases
    Shizuku, Masato
    Shibata, Masahiro
    Okumura, Mai
    Takeuchi, Dai
    Kikumori, Toyone
    Mizuno, Yutaka
    BREAST CANCER, 2020, 27 (06) : 1065 - 1071
  • [45] Level Of Urine N-Telopeptide Of Type I Collagen In Patients Treated With Antiepileptic Drug
    Bin, J. H.
    Chung, S. Y.
    Park, Y. S.
    EPILEPSIA, 2018, 59 : S259 - S260
  • [46] N-telopeptide and bone mineral density in older men and women: The Rancho Bernardo Study
    Johnson, S. R.
    McCarthy, D.
    Laughlin, G. A.
    Barrett-Connor, E.
    BONE, 2009, 44 (02) : S417 - S417
  • [47] Molecular modeling of the N-telopeptide domain of type 1 collagen and implications for intermolecular registration
    Malone, JP
    George, A
    Veis, A
    JOURNAL OF DENTAL RESEARCH, 1996, 75 : 1443 - 1443
  • [48] Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBIscintigraphy and other biochemical markers of disease activity
    Alexandrakis, MG
    Kyriakou, DS
    Passam, FH
    Malliaraki, N
    Vlachonikolis, IG
    Karkavitsas, N
    HEMATOLOGICAL ONCOLOGY, 2003, 21 (01) : 17 - 24
  • [49] SPECTROSCOPIC STUDY OF THE TYPE-I COLLAGEN ALPHA-1-CHAIN N-TELOPEPTIDE
    SCOTT, PG
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (01) : 167 - 168
  • [50] Serum gla-type osteocalcin, osteoprotegerin, and urinary cross-linked N-telopeptide as markers in glueocorticoid-induced osteoporosis.
    Tanaka, I
    Oshima, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S128 - S128